Argatroban (Hospira, Inc.)


Welcome to the PulseAid listing for the Argatroban drug offered from Hospira, Inc.. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Argatroban
SUBSTANCE NAME: ARGATROBAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-16
END MARKETING DATE: 0000-00-00


Argatroban HUMAN PRESCRIPTION DRUG Details:

Item DescriptionArgatroban from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2017-01-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1140_5e4d31b2-2e02-4703-9f76-d889ee3e8930
PRODUCT NDC: 0409-1140
APPLICATION NUMBER: ANDA204120

Other ARGATROBAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eagle Pharmaceuticals, Inc.Argatroban
Fresenius Kabi USA, LLCArgatroban
Gland Pharma LimitedArgatroban
GlaxoSmithKline LLCARGATROBAN
Hospira, Inc.Argatroban
Par Pharmaceutical, Inc.Argatroban
Sandoz IncArgatroban
Teva Parenteral Medicines, Inc.Argatroban
West-Ward Pharmaceuticals CorpArgatroban